BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

380 related articles for article (PubMed ID: 31498036)

  • 1. [Nuclear medicine diagnostics, therapy and theranostics in the context of modern oncology].
    Schaefer N; Prior J
    Ther Umsch; 2019 Sep; 76(4):167-172. PubMed ID: 31498036
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Theranostics in Nuclear Medicine: Emerging and Re-emerging Integrated Imaging and Therapies in the Era of Precision Oncology.
    Gomes Marin JF; Nunes RF; Coutinho AM; Zaniboni EC; Costa LB; Barbosa FG; Queiroz MA; Cerri GG; Buchpiguel CA
    Radiographics; 2020 Oct; 40(6):1715-1740. PubMed ID: 33001789
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An introduction to the clinical practice of theranostics in oncology.
    Turner JH
    Br J Radiol; 2018 Nov; 91(1091):20180440. PubMed ID: 30179054
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Application of Theranostics in Oncology.
    Lymperopoulos G; Lymperopoulos P; Alikari V; Dafogianni C; Zyga S; Margari N
    Adv Exp Med Biol; 2017; 989():119-128. PubMed ID: 28971421
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Theranostic applications of antibodies in oncology.
    Fleuren ED; Versleijen-Jonkers YM; Heskamp S; van Herpen CM; Oyen WJ; van der Graaf WT; Boerman OC
    Mol Oncol; 2014 Jun; 8(4):799-812. PubMed ID: 24725480
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Future of Theranostics: An Outlook on Precision Oncology in Nuclear Medicine.
    Langbein T; Weber WA; Eiber M
    J Nucl Med; 2019 Sep; 60(Suppl 2):13S-19S. PubMed ID: 31481583
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Theranostics and metabolotheranostics for precision medicine in oncology.
    Bhujwalla ZM; Kakkad S; Chen Z; Jin J; Hapuarachchige S; Artemov D; Penet MF
    J Magn Reson; 2018 Jun; 291():141-151. PubMed ID: 29705040
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Personalized oncology: recent advances and future challenges.
    Kalia M
    Metabolism; 2013 Jan; 62 Suppl 1():S11-4. PubMed ID: 22999010
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nuclear medicine theranostics comes of age.
    Herrmann K; Kraus BJ; Hadaschik B; Kunikowska J; van Poppel H; N'Dow J; Sartor O; Oyen WJG
    Lancet Oncol; 2021 Nov; 22(11):1497-1498. PubMed ID: 34735807
    [No Abstract]   [Full Text] [Related]  

  • 10. Theranostic approaches in nuclear medicine: current status and future prospects.
    Filippi L; Chiaravalloti A; Schillaci O; Cianni R; Bagni O
    Expert Rev Med Devices; 2020 Apr; 17(4):331-343. PubMed ID: 32157920
    [No Abstract]   [Full Text] [Related]  

  • 11. General Concepts in Theranostics.
    Nunes RF; Zuppani RMF; Coutinho AM; Barbosa FG; Sapienza MT; Marin JFG; Buchpiguel CA
    PET Clin; 2021 Jul; 16(3):313-326. PubMed ID: 34053576
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An Impressive Approach in Nuclear Medicine: Theranostics.
    Vahidfar N; Eppard E; Farzanehfar S; Yordanova A; Fallahpoor M; Ahmadzadehfar H
    PET Clin; 2021 Jul; 16(3):327-340. PubMed ID: 34053577
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nuclear Medicine Cancer Care-Current Status and Future Directions for Radiopharmaceutical Diagnostics and Theranostics for Cancer.
    O'Brien SR; Mankoff DA
    Cancer J; 2024 May-Jun 01; 30(3):140-141. PubMed ID: 38753747
    [No Abstract]   [Full Text] [Related]  

  • 14. Theranostics in nuclear medicine practice.
    Yordanova A; Eppard E; Kürpig S; Bundschuh RA; Schönberger S; Gonzalez-Carmona M; Feldmann G; Ahmadzadehfar H; Essler M
    Onco Targets Ther; 2017; 10():4821-4828. PubMed ID: 29042793
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Theranostics - a sure cure for cancer after 100 years?
    Song Y; Zou J; Castellanos EA; Matsuura N; Ronald JA; Shuhendler A; Weber WA; Gilad AA; Müller C; Witney TH; Chen X
    Theranostics; 2024; 14(6):2464-2488. PubMed ID: 38646648
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Invited Commentary: Nuclear Theranostics-The Path Forward.
    Greenspan BS; Jadvar H
    Radiographics; 2020 Oct; 40(6):1741-1742. PubMed ID: 33016813
    [No Abstract]   [Full Text] [Related]  

  • 17. Theranostic Nanomedicine; A Next Generation Platform for Cancer Diagnosis and Therapy.
    Sharma R; Mody N; Agrawal U; Vyas SP
    Mini Rev Med Chem; 2017; 17(18):1746-1757. PubMed ID: 26891932
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Companion Diagnostics and Molecular Imaging.
    Puranik AD; Kulkarni HR; Baum RP
    Cancer J; 2015; 21(3):213-7. PubMed ID: 26049701
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Recent advances in theranostics and challenges for the future.
    Turner JH
    Br J Radiol; 2018 Nov; 91(1091):20170893. PubMed ID: 29565650
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bench-to-Bedside Theranostics in Nuclear Medicine.
    Jokar N; Assadi M; Yordanova A; Ahmadzadehfar H
    Curr Pharm Des; 2020; 26(31):3804-3811. PubMed ID: 32067609
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.